Literature DB >> 21302809

Invadopodia formation by bladder tumor cells.

Mihoko Sutoh1, Yasuhiro Hashimoto, Takahiro Yoneyama, Hayato Yamamoto, Shingo Hatakeyama, Takuya Koie, Akiko Okamoto, Kanemitsu Yamaya, Hisao Saitoh, Tomihisa Funyu, Toshiya Nakamura, Tatsusuke Sato, Chikara Ohyama, Shigeru Tsuboi.   

Abstract

A major cause of death in patients with bladder tumors is recurrence with metastasis. Bladder tumor metastasis is largely dependent upon the invasive capacity of tumor cells. Tumor cell invasion is mainly mediated by actin-rich protrusive membrane structures called invadopodia. The formation of invadopodia was observed in various types of invasive tumors such as breast cancer and melanomas. However, invadopodia formation so far has not been described in bladder tumor cells. We here report that human bladder tumor cells form functionally active invadopodia. By using a confocal laser scanning microscope, we demonstrated that invasive bladder tumor cell lines, YTS-1 and T24, with high Matrigel degradation activity form invadopodia but that noninvasive bladder tumor cell lines, RT4 and KK-47, form no detectable invadopodia. Invadopodia formed by YTS-1 cells had the ability to secrete matrix metalloproteases and degrade extracellular matrix to invade surrounding areas. Moreover, we observed that primary tumor cells obtained from patients with invasive bladder tumors also form invadopodia, validating the results from bladder tumor cell lines. Our results provide evidence that invasive human bladder tumor cells form invadopodia for tumor invasion.

Entities:  

Mesh:

Year:  2010        PMID: 21302809     DOI: 10.3727/096504010x12875107808008

Source DB:  PubMed          Journal:  Oncol Res        ISSN: 0965-0407            Impact factor:   5.574


  10 in total

1.  The role of LIM and SH3 protein-1 in bladder cancer metastasis.

Authors:  Misaki Sato; Mihoko Sutoh Yoneyama; Shingo Hatakeyama; Tomihisa Funyu; Tadashi Suzuki; Chikara Ohyama; Shigeru Tsuboi
Journal:  Oncol Lett       Date:  2017-08-23       Impact factor: 2.967

Review 2.  The interplay between the proteolytic, invasive, and adhesive domains of invadopodia and their roles in cancer invasion.

Authors:  Or-Yam Revach; Benjamin Geiger
Journal:  Cell Adh Migr       Date:  2014       Impact factor: 3.405

Review 3.  Invadosomes in their natural habitat.

Authors:  Elisabeth Génot; Bojana Gligorijevic
Journal:  Eur J Cell Biol       Date:  2014-10-23       Impact factor: 4.492

Review 4.  Invadosomes are coming: new insights into function and disease relevance.

Authors:  Elyse K Paterson; Sara A Courtneidge
Journal:  FEBS J       Date:  2017-06-22       Impact factor: 5.542

Review 5.  Mechanisms and roles of podosomes and invadopodia.

Authors:  Stefan Linder; Pasquale Cervero; Robert Eddy; John Condeelis
Journal:  Nat Rev Mol Cell Biol       Date:  2022-09-14       Impact factor: 113.915

6.  A novel Pyk2-derived peptide inhibits invadopodia-mediated breast cancer metastasis.

Authors:  Shams Twafra; Chana G Sokolik; Tal Sneh; Kolluru D Srikanth; Tomer Meirson; Alessandro Genna; Jordan H Chill; Hava Gil-Henn
Journal:  Oncogene       Date:  2022-10-18       Impact factor: 8.756

Review 7.  The regulation of MMP targeting to invadopodia during cancer metastasis.

Authors:  Abitha Jacob; Rytis Prekeris
Journal:  Front Cell Dev Biol       Date:  2015-02-02

8.  Inhibition of Radiation and Temozolomide-Induced Invadopodia Activity in Glioma Cells Using FDA-Approved Drugs.

Authors:  Clarissa A Whitehead; Hong P T Nguyen; Andrew P Morokoff; Rodney B Luwor; Lucia Paradiso; Andrew H Kaye; Theo Mantamadiotis; Stanley S Stylli
Journal:  Transl Oncol       Date:  2018-09-13       Impact factor: 4.243

9.  TC10 regulates breast cancer invasion and metastasis by controlling membrane type-1 matrix metalloproteinase at invadopodia.

Authors:  Maren Hülsemann; Colline Sanchez; Polina V Verkhusha; Vera Des Marais; Serena P H Mao; Sara K Donnelly; Jeffrey E Segall; Louis Hodgson
Journal:  Commun Biol       Date:  2021-09-16

10.  Targeting invadopodia-mediated breast cancer metastasis by using ABL kinase inhibitors.

Authors:  Tomer Meirson; Alessandro Genna; Nikola Lukic; Tetiana Makhnii; Joel Alter; Ved P Sharma; Yarong Wang; Abraham O Samson; John S Condeelis; Hava Gil-Henn
Journal:  Oncotarget       Date:  2018-04-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.